Oral Oncology
Volume 38, Issue 1 , Pages 16-22 , January 2002

Okadaic acid stimulates apoptosis through expression of Fas receptor and Fas ligand in human oral squamous carcinoma cells

  • K. Goto

      Affiliations

    • Department of Histology and Oral Histology, School of Dentistry, The University of Tokushima, 3-18-15, Kuramoto, Tokushima 770-8504, Japan
    • First Department of Oral and Maxillofacial Surgery, Kyushu Dental College, Kitakyushu 803-8580, Japan
    • ,
  • J. Fukuda

      Affiliations

    • First Department of Oral and Maxillofacial Surgery, Kyushu Dental College, Kitakyushu 803-8580, Japan
    • ,
  • T. Haneji

      Affiliations

    • Department of Histology and Oral Histology, School of Dentistry, The University of Tokushima, 3-18-15, Kuramoto, Tokushima 770-8504, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81-88-633-7321; fax: +81-88-633-7342

Received 23 October 2000 ,Revised 8 November 2000 ,Accepted 22 November 2000.

References 

  1. Gjertsen BT, Døskeland SO. Protein phosphorylation in apoptosis. Biochimica et Biophysica Acta. 1995;1269:187–199
  2. Hunter T. Protein kinases and phosphatases (the yin and yang of protein phosphorylation and signaling). Cell. 1995;80:225–236
  3. Berndt N. Protein dephosphorylation and the intracellular control of the cell number. Frontiers in Biosciences. 1999;1:D22–42
  4. Gross TG, Scheel-Toellner D, Henriquez NV, Deacon E, Salmon M, Lord JM. Serine/Threonine protein kinases and apoptosis. Experimental Cell Research. 2000;256:34–41
  5. Bialojan C, Takai A. Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Biochemical Journal. 1988;256:283–290
  6. Suganuma M, Fujiki H, Suguri H, Yoshizawa S, Hirota M, Nakayasu M, et al.  Okadaic acid: an additional non-phorbol-12-tetradecanoate-13-acetate-type tumor promoter. Proceedings of the National Academy of Sciences USA. 1988;85:1768–1771
  7. Cohen P, Holmes CFB, Tsukitani Y. Okadaic acid (a new probe for the study of cellular regulation). Trends in Biochemical Sciences. 1990;15:98–102
  8. Bøe R, Gjertsen BT, Vintermyr OK, Houge G, Lanotte M, Døskeland SO. The protein phosphatase inhibitor okadaic acid induces morphological changes typical of apoptosis in mammalian cells. Experimental Cell Research. 1991;195:237–246
  9. Kiguchi K, Glesne D, Chubb CH, Fujiki H, Huberman E. Differential induction of apoptosis in human breast tumor cells by okadaic acid and related inhibitions of protein phosphatases 1 and 2A. Cell Growth and Differentiation. 1994;5:995–1004
  10. Morana SJ, Wolf CM, Li JF, Reynolds JE, Brown MK, Eastman A. The involvement of protein phosphatase in the activation of ICE/CED-3 protease, intracellular acidification, DNA digestion, and apoptosis. Journal of Biological Chemistry. 1996;271:18 263–18 271
  11. von Zezschwitz C, Vorwerk H, Tergau F, Steinfelder HJ. Apoptosis induction by inhibitors of Ser/Thr phosphatases 1 and 2A is associated with transglutaminase activation in two different human epithelial tumour lines. FEBS Letters. 1997;413:147–151
  12. Riordan FA, Foroni L, Hoffbrand AV, Mehta AB, Wickremasinghe RG. Okadaic acid-induced apoptosis of HL60 leukemia cells is preceded by destabilization of bcl-2 mRNA and downregulation of bcl-2 protein. FEBS Letters. 1998;435:195–198
  13. Morimoto Y, Ohba T, Kobayashi S, Haneji T. The protein phosphatase inhibitors okadaic acid and calyculin A induce apoptosis in human osteoblastic cells. Experimental Cell Research. 1997;230:181–186
  14. Morimoto Y, Morimoto H, Kobayashi S, Ohba T, Haneji T. The protein phosphatase inhibitors, okadaic acid and calyculin A, induce apoptosis in human submandibular gland ductal cell line HSG cells. Oral Diseases. 1999;5:104–110
  15. Fujita M, Seta C, Fukuda J, Kobayashi S, Haneji T. Induction of apoptosis in human oral squamous carcinoma cell lines by protein phosphatase inhibitors. European Journal of Cancer Part B Oral Oncology. 1999;35:401–408
  16. Arends MJ, Wyllie AH. Apoptosis (mechanisms and roles in pathology). International Review of Experimental Pathology. 1991;32:223–254
  17. Kerr JFR, Winterford CM, Harmon BV. Apoptosis (its significance in cancer and cancer therapy). Cancer. 1994;73:2013–2026
  18. Jacobson MD, Weil M, Raff MC. Programmed cell death in animal development. Cell. 1997;88:347–354
  19. Kaufmann ST, Earnshaw WC. Induction of apoptosis by cancer chemotherapy. Experimental Cell Research. 2000;256:42–49
  20. Yonehara S, Ishii A, Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. Journal of Experimental Medicine. 1989;169:1747–1756
  21. Trauth BC, Klas C, Peters AMJ, Matzku S, Moller P, Falk W, et al.  Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science. 1989;245:301–305
  22. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, et al.  The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell. 1991;66:233–243
  23. Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell. 1993;75:1169–1178
  24. Nagata S, Golstein P. The Fas death factor. Science. 1995;267:1449–1456
  25. Walczak H, Krammer PH. The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems. Experimental Cell Research. 2000;256:58–66
  26. Yoshioka C, Muraki Y, Fukuda J, Haneji T, Kobayashi N. Identification of the Fas antigen in human gingiva. Journal of Dental Research. 1996;75:1353–1357
  27. Muraki Y, Yoshioka C, Fukuda J, Haneji T, Kobayashi N. Immunohistochemical detection of Fas antigen in oral epithelia. Journal of Oral Pathology and Medicine. 1997;26:57–62
  28. Muraki Y, Yoshioka C, Tateishi A, Fukuda J, Haneji T, Kobayashi N. Localization of Fas antigen in oral squamous cell carcinoma. British Journal of Oral and Maxillofacial Surgery. 1999;37:37–40
  29. Muraki Y, Yoshioka-Seta C, Tateishi A, Fukuda J, Haneji T, Kobayashi N. Fas expression and prognosis of oral squamous cell carcinoma. International Journal of Oral and Maxillofacial Surgery 2000 (in press).
  30. Teicher BA, Holden SA, Kelley MJ, Shea TC, Cucchi CA, Rosowsky A, et al.  Characterization of a human squamous carcinoma cell line resistant to cis diamminedichloroplatinum (II). Cancer Research. 1987;47:388–393
  31. Koji T, Kobayashi N, Nakanishi Y, Yoshii A, Hashimoto S, Shibata Y, et al.  Immunohistochemical localization of Fas antigen in paraffin sections with rabbit antibodies against human synthetic Fas peptides. Acta Histochemia et Cytochemica. 1994;27:459–463
  32. Ashkenazi A, Dixit VM. Death receptors (signaling and modulation). Science. 1998;281:1305–1308
  33. Seta C, Fujita M, Muraki Y, Fukuda J, Kobayashi S, Haneji T. Fas expression and Fas monoclonal antibody-induced apoptosis in human squamous cell carcinoma cell line, SCC-25. Journal of Oral Pathology and Medicine. 2000;29:271–278
  34. Itoh N, Tsujimoto Y, Nagata S. Effect of bcl-2 on Fas antigen-mediated cell death. Journal of Immunology. 1993;151:621–627
  35. Ghosh S, Schroeter D, Paweletz N. Okadaic acid overrides the S-phase check point and accelerates progression of G2-phase to induce premature mitosis in HeLa cells. Experimental Cell Research. 1996;227:165–169
  36. Giese G, Wiegers W, Kubbies M, Scherbarth A, Traub PM. Okadaic acid co-induces vimentin expression and cell cycle arrest in MPC-11 mouse plasmacytoma cells. Journal of Cellular Physiology. 1995;163:145–154
  37. Song Q, Baxter GD, Kovacs EM, Findik D, Lavin MF. Inhibition of apoptosis in human tumor cells by okadaic acid. Journal of Cellular Physiology. 1992;153:550–556
  38. Ohoka Y, Nakai Y, Mukai M, Iwata M. Okadaic acid inhibits glucocorticoid-induced apoptosis in T cell hybridomas at its late stage. Biochemical and Biophysical Research Communications. 1993;197:916–921
  39. Caricchio R, Reap EA, Cohen PL. Fas/Fas ligand interactions are involved in ultraviolet-B-induced human lymphocyte apoptosis. Journal of Immunology. 1998;161:241–251
  40. Haldar S, Jena N, Croce CM. Inactivation of Bcl-2 by phosphorylation. Proceedings of the National Academy of Sciences USA. 1995;92:4507–4511

PII: S1368-8375(00)00134-2

Oral Oncology
Volume 38, Issue 1 , Pages 16-22 , January 2002

Article Tools

* Image Usage & Resolution